Thus, the regimen of adoptive cell transfer with lymphopenic conditioning and tumor antigen vaccination followed by IL-21 + IL-2 therapy was curative in mice with established tumors, and produced a long-term tumor-specific memory response capable of protecting against a secondary challenge with the original tumor. This evidence concerns the gene IL21 and neoplasm.